Lung Adenocarcinoma

Universal Diagnostics touts blood-based lung cancer test

Presented at the International Association for the Study of Lung Cancer (IASLC) 2020 World Conference, the test uses methylation status measurement of the tumor-derived portion from cell-free DNA (cfDNA) in plasma for patient classification. Researchers examined plasma samples of 37 lung cancer patients and 71 asymptomatic age, gender, and smoking-history matching controls.

January 28, 2021

Google reports pathology AI helps predict survival in cancer patients

The deep-learning system was developed and tested using histopathology slides for patients with 10 cancer types -- including bladder cancer, invasive breast cancer, and head and neck squamous cell carcinoma -- drawing from publicly available data from the Cancer Genome Atlas (TCGA) program.

June 17, 2020

Liquid biopsy results help TARGET cancer treatments in U.K. study

In an ideal world, all cancer patients would get a personalized treatment regimen based on the molecular profile of their particular tumor. But tissue biopsies are invasive, and results may become outdated over time as cancers evolve.

April 22, 2019